NCT04940507View on ClinicalTrials.gov

BRAINFUL (BRAIN Tumor Focused Ultrasound-enabled Liquid Biopsy) Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Brain NeoplasmsLiquid Biopsy
Interventions
PROCEDURE

Magnetic Resonance Guided Focused Ultrasound Tumor Ablation and Liquid Biopsy Acquisition

Partial ablation of tumor using ExAblate Neuro 4000 device (InSightec Ltd, Tirat Carmel, Israel) and blood and CSF draws for liquid biopsy

PROCEDURE

Magnetic Resonance Guided Focused Ultrasound Thalamotomy

Ablation of VIM nucleus of thalamus with MRgFUS using ExAblate Neuro 4000 Device (InSightec Ltd, Tirat Carmel, Israel) and blood draws.

Trial Locations (1)

M5T 2S8

Toronto Western Hospital, University Health Network, Toronto

All Listed Sponsors
collaborator

Canadian Cancer Society (CCS)

OTHER

collaborator

Brain Canada

OTHER

lead

University Health Network, Toronto

OTHER